New research has identified circulating cell subtypes with ties to better or worse outcomes in individuals with prostate cancer.
The Bay Area firm is planning to launch a low-cost, microfluidics-based infectious disease diagnostic called the Simple Chip in the next few years.
The company is providing several of its Parsortix instruments to the CANCER-ID consortium as part of an effort to establish liquid biopsy in routine clinical practice.
The company is preparing a blood-based test for early-stage pancreatic cancer that it hopes to have on the market by 2019.
The agency is sending an Oxford Nanopore MinIon to the International Space Station to determine if the technology's microfluidic system can work in microgravity.
The aim of the project, called Metafluidics, is to replace cumbersome conventional approaches with a cheaper, faster, and higher-throughput microfluidics platform.
Fluidic Analytics, a Cambridge University spinout, has licensed the technology and plans to commercialize an instrument for the research market in mid-2016.
The new device rotates heating blocks to contact a stationary sample and is meant to be integrated with a plug-and-play digital microfluidics hub.
NeoPrep combines electrowetting technology that Illumina acquired when it purchased Advanced Liquid Logic in 2013 with microfluidics.
The UK Biobank will use Trinean's technology to quantify molecules during the DNA extraction stage of a large genotyping project.
Gene drives might run into biological resistance, the Economist reports.
Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.
Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.
In Science this week: full CRISPR locus integration complex structure, and more.